These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 18474571)
1. Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice. Song CH; Furuoka H; Kim CL; Ogino M; Suzuki A; Hasebe R; Horiuchi M J Gen Virol; 2008 Jun; 89(Pt 6):1533-1544. PubMed ID: 18474571 [TBL] [Abstract][Full Text] [Related]
2. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion. Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of peripheral administration of an anti-prion protein antibody on mice infected with prions. Ohsawa N; Song CH; Suzuki A; Furuoka H; Hasebe R; Horiuchi M Microbiol Immunol; 2013 Apr; 57(4):288-97. PubMed ID: 23586633 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of prion propagation in scrapie-infected mouse neuroblastoma cell lines using mouse monoclonal antibodies against prion protein. Miyamoto K; Nakamura N; Aosasa M; Nishida N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H Biochem Biophys Res Commun; 2005 Sep; 335(1):197-204. PubMed ID: 16061207 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the anti-prion mechanism of four different anti-prion compounds, anti-PrP monoclonal antibody 44B1, pentosan polysulfate, chlorpromazine, and U18666A, in prion-infected mouse neuroblastoma cells. Yamasaki T; Suzuki A; Hasebe R; Horiuchi M PLoS One; 2014; 9(9):e106516. PubMed ID: 25181483 [TBL] [Abstract][Full Text] [Related]
14. Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP Pankiewicz JE; Sanchez S; Kirshenbaum K; Kascsak RB; Kascsak RJ; Sadowski MJ Mol Neurobiol; 2019 Mar; 56(3):2073-2091. PubMed ID: 29987703 [TBL] [Abstract][Full Text] [Related]
15. Tracing conformational transition of abnormal prion proteins during interspecies transmission by using novel antibodies. Ushiki-Kaku Y; Endo R; Iwamaru Y; Shimizu Y; Imamura M; Masujin K; Yamamoto T; Hattori S; Itohara S; Irie S; Yokoyama T J Biol Chem; 2010 Apr; 285(16):11931-6. PubMed ID: 20177064 [TBL] [Abstract][Full Text] [Related]
16. Cell-surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation. Kim CL; Karino A; Ishiguro N; Shinagawa M; Sato M; Horiuchi M J Gen Virol; 2004 Nov; 85(Pt 11):3473-3482. PubMed ID: 15483265 [TBL] [Abstract][Full Text] [Related]
17. Anti-PrP Mab 6D11 suppresses PrP(Sc) replication in prion infected myeloid precursor line FDC-P1/22L and in the lymphoreticular system in vivo. Sadowski MJ; Pankiewicz J; Prelli F; Scholtzova H; Spinner DS; Kascsak RB; Kascsak RJ; Wisniewski T Neurobiol Dis; 2009 May; 34(2):267-78. PubMed ID: 19385058 [TBL] [Abstract][Full Text] [Related]
18. Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations. Moore RA; Timmes A; Wilmarth PA; Priola SA Proteomics; 2010 Aug; 10(15):2858-69. PubMed ID: 20518029 [TBL] [Abstract][Full Text] [Related]
19. Development of antibody fragments for immunotherapy of prion diseases. Campana V; Zentilin L; Mirabile I; Kranjc A; Casanova P; Giacca M; Prusiner SB; Legname G; Zurzolo C Biochem J; 2009 Mar; 418(3):507-15. PubMed ID: 19000036 [TBL] [Abstract][Full Text] [Related]